长兴制药 (835269.OC)

+ 收藏

现金流量表(长兴制药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 316,504,296.57436,581,066.01233,381,736.52310,090,100.69150,670,835.86
 收到的税费返还(元) 7,644,536.2519,634,885.0010,267,066.8715,014,327.147,645,111.31
 收到其他与经营活动有关的现金(元) 5,388,833.7817,088,018.098,954,661.7619,216,943.258,731,637.07
 经营活动现金流入小计(元) 329,537,666.60473,303,969.10252,603,465.15344,321,371.08167,047,584.24
 购买商品、接受劳务支付的现金(元) 125,778,193.23168,464,746.2295,403,717.54130,838,088.4973,601,006.79
 支付给职工以及为职工支付的现金(元) 23,808,120.5339,518,883.7221,682,357.5234,284,682.9618,321,081.16
 支付的各项税费(元) 22,566,525.6226,749,581.0717,181,874.5726,563,120.8314,676,499.33
 支付其他与经营活动有关的现金(元) 148,425,944.07157,537,347.9656,652,729.5093,029,016.9733,350,002.50
 经营活动现金流出小计(元) 320,578,783.45392,270,558.97190,920,679.13284,714,909.25139,948,589.78
 经营活动产生的现金流量净额(元) 8,958,883.1581,033,410.1361,682,786.0259,606,461.8327,098,994.46
二、投资活动产生的现金流量
 取得投资收益收到的现金(元) ---89,125.6389,125.63
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) 4,300.00-24,200.0034,000.0034,000.00
 收到其他与投资活动有关的现金(元) -3,233,000.00-13,400,000.0013,400,000.00
 投资活动现金流入小计(元) 4,300.003,233,000.0024,200.0013,523,125.6313,523,125.63
 购建固定资产、无形资产和其他长期资产支付的现金(元) 8,200,116.107,541,632.173,273,495.5411,923,573.787,433,559.10
 支付其他与投资活动有关的现金(元) ---13,671,200.0013,400,000.00
 投资活动现金流出小计(元) 8,200,116.107,541,632.173,273,495.5425,594,773.7820,833,559.10
 投资活动产生的现金流量净额(元) -8,195,816.10-4,308,632.17-3,249,295.54-12,071,648.15-7,310,433.47
三、筹资活动产生的现金流量
 分配股利、利润或偿付利息支付的现金(元) 29,908,025.0032,333,000.0032,333,000.00--
 支付其他与筹资活动有关的现金(元) 208,799.00202,717.00202,717.00196,813.00196,813.00
 筹资活动现金流出小计(元) 30,116,824.0032,535,717.0032,535,717.00196,813.00196,813.00
 筹资活动产生的现金流量净额(元) -30,116,824.00-32,535,717.00-32,535,717.00-196,813.00-196,813.00
四、汇率变动对现金及现金等价物的影响(元) 140,982.79268,071.22195,689.181,156,567.33304,723.77
五、现金及现金等价物净增加额(元) -29,212,774.1644,457,132.1826,093,462.6648,494,568.0119,896,471.76
 加:期初现金及现金等价物余额(元) 182,705,452.11138,248,319.93138,248,319.9389,753,751.9289,753,751.92
 期末现金及现金等价物余额(元) 153,492,677.95182,705,452.11164,341,782.59138,248,319.93109,650,223.68
补充资料:
 净利润(元) 42,661,974.4866,917,366.3636,187,437.1760,425,383.7128,770,826.57
 资产减值准备(元) -227,331.692,864,144.09-490,872.422,314,572.571,058,466.19
 固定资产和投资性房地产折旧(元) 4,921,790.0410,304,886.625,162,915.899,503,116.504,623,679.15
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 4,921,790.0410,304,886.625,162,915.899,503,116.504,623,679.15
 无形资产摊销(元) 106,808.16213,616.32106,808.16225,408.80118,600.64
 处置固定资产、无形资产和其他长期资产的损失(元) ----183,832.04-189,024.24
 固定资产报废损失(元) 863.33628,782.2386,333.8372,912.189,918.47
 财务费用(元) -138,687.17-260,188.97-188,901.47-900,864.31-300,255.51
 投资损失(元) ---182,074.37-
 递延所得税(元) 27,171.06412,101.0522,588.14475,726.39-108,045.78
  其中:递延所得税资产减少(元) 27,171.06412,101.0522,588.14475,726.39-108,045.78
 存货的减少(元) -7,500,211.97-22,139,103.51-10,916,882.50-17,335,698.935,176,047.26
 经营性应收项目的减少(元) -34,697,671.84-9,208,704.745,669,151.19-27,871,595.88-17,221,078.52
 经营性应付项目的增加(元) 3,707,269.8727,651,042.5424,477,110.7829,388,129.443,613,549.11
 其他(元) -3,455,650.381,470,234.213,165,765.711,497,879.60
 现金的期末余额(元) 153,492,677.95182,705,452.11164,341,782.59138,248,319.93109,650,223.68
 减:现金的期初余额(元) 182,705,452.11138,248,319.93138,248,319.9389,753,751.9289,753,751.92
 现金及现金等价物的净增加额(元) -29,212,774.1644,457,132.1826,093,462.6648,494,568.0119,896,471.76
公告日期 2024-08-292024-03-182023-08-312023-04-282022-08-31
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院